Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/06/20 → 31/05/23 |
Funding
- British Heart Foundation BHF: £14,390.00
RABEP2 is a novel GSK3 substrate that represents a single therapeutic target to reduce both hyperglycemia and microvascular disease in diabetes
- Gould, Gwyn (Principal Investigator)
Project: Research